Myriad Genetics Inc (NASDAQ:MYGN)
| 19.27 Delayed Data As of 3:59pm ET |  -1.10 / -5.40%Today’s Change | 13.92 Today|||52-Week Range 28.18 | +32.80% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 20.37 |
| Today’s open | 19.72 |
| Day’s range | 19.15 - 19.83 |
| Volume | 15,772 |
| Average volume (3 months) | 671,445 |
| Market cap | $1.7B |
Data as of 3:59pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | +87.01% |
| Earnings growth (this year) | -2,066.66% |
| Earnings growth (next 5 years) | -10.28% |
| Revenue growth (last year) | +8.14% |
| P/E ratio | NM |
| Price/Sales | 3.12 |
| Price/Book | 1.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VIVOMeridian Bioscience ... | +0.01 | +0.01% |
| VCYTVeracyte Inc | -1.46 | -5.61% |
| ---- | ||
| CLDXCelldex Therapeutics... | -2.09 | -4.52% |
Data as of 4:00pm ET, 01/30/2023
Financials
| Next reporting date | February 23, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $690.6M |
| Annual profit (last year) | -$27.2M |
| Net profit margin | -3.94% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
